Comprehensive Cancer Centers Clinical Research
Comprehensive is affiliated for academic-based oncology research with UCLA TRIO-US, Memorial Sloan Kettering Cancer Center and leading pharmaceutical companies—including AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Genentech, Gilead, Janssen, Lilly, Merck,Novartis, Pfizer and Regeneron—to bring groundbreaking treatments close to home, some of which are not available anywhere else in the world.
- Comprehensive has a long history of participating in clinical research studies. Comprehensive has developed one of the largest Phase I clinical trial programs in Nevada; developed extensive research programs for genitourinary cancer treatments (prostate, kidney, and bladder cancers) and gastrointestinal cancer treatments, and has developed extensive research programs for breast cancer, lung cancer, head & neck cancer, blood cancer and skin cancer.
- Comprehensive participates in more than 100 Phase I, Phase II, Phase III and Phase IV clinical research studies each year.
- Comprehensive has helped develop more than 100 FDA approved cancer therapies.
You can learn more about the benefits here.
Right Here in Nevada
Comprehensive has developed one of the largest Phase I research programs in Nevada, with extensive research programs for breast cancer, gastrointestinal malignancies, genitourinary malignancies and skin cancer. All right here in Nevada. Call 702-952-3350 now or fill out our contact form for more information.
